Wisconsin Administrative Code › Department of Natural Resources › NR 600-699 - Environmental Protection - Hazardous Waste Management › Chapter NR 666 - Standards For Managing Specific Hazardous Wastes And Specific Types Of Hazardous Waste Management Facilities › Subchapter P - Hazardous Waste Pharmaceuticals › Section NR 666.509 - Shipping potentially creditable hazardous waste pharmaceuticals from a healthcare facility or a reverse distributor to a reverse distributor

Current through June 24, 2024
(1)
				  SHIPPING POTENTIALLY CREDITABLE HAZARDOUS WASTE PHARMACEUTICALS. A healthcare
				  facility or a reverse distributor who transports or offers for transport
				  potentially creditable hazardous waste pharmaceuticals off-site to a reverse
				  distributor shall comply with all applicable U.S. department of transportation
				  regulations in 49 CFR parts 171 to 180 for a ny potentially creditable
				  hazardous waste pharmaceutical that meets the definition of hazardous material
				  in
				  49 CFR
				  171.8.
Note:
For purposes of the department of
					 transportation regulations, a material is considered a hazardous waste if it is
					 subject to the hazardous waste manifest requirements specified in ch. NR 662.
					 Because a potentially creditable hazardous waste pharmaceutical does not
					 require a manifest, it is not considered hazardous waste under the department
					 of transportation regulations.
(2) DELIVERY CONFIRMATION. Upon receipt of
				  each shipment of potentially creditable hazardous waste pharmaceuticals, the
				  receiving reverse distributor shall provide confirmation, paper or electronic,
				  to the healthcare facility or reverse distributor that initiated the shipment
				  that the shipment of potentially creditable hazardous waste pharmaceuticals has
				  arrived at its destination and is under the custody and control of the reverse
				  distributor.
(3) PROCEDURES FOR
				  WHEN DELIVERY CONFIRMATION IS NOT RECEIVED WITHIN 35 CALENDAR DAYS. If a
				  healthcare facility or reverse distributor initiates a shipment of potentially
				  creditable hazardous waste pharmaceuticals to a reverse distributor and does
				  not receive delivery confirmation within 35 calendar days from the date that
				  the shipment of potentially creditable hazardous waste pharmaceuticals was
				  sent, the healthcare facility or reverse distributor that initiated the
				  shipment shall contact the carrier and the intended recipient, that is the
				  reverse distributor, promptly to report that the delivery confirmation was not
				  received and to determine the status of the potentially creditable hazardous
				  waste pharmaceuticals.
(4)
				  EXPORTING POTENTIALLY CREDITABLE HAZARDOUS WASTE PHARMACEUTICALS. A healthcare
				  facility or reverse distributor that sends potentially creditable hazardous
				  waste pharmaceuticals to a foreign destination shall comply with the applicable
				  sections of subch. H of ch. NR 662, except the manifesting requirement under s.
				  NR
				  662.083(3), in addition to subs. (1)
				  to (3).
(5) IMPORTING POTENTIALLY
				  CREDITABLE HAZARDOUS WASTE PHARMACEUTICALS. Any person that imports potentially
				  creditable hazardous waste pharmaceuticals into the United States is subject to
				  subs. (1) to (3) in lieu of subch. H of ch. NR 662. Immediate ly after the
				  potentially creditable hazardous waste pharmaceuticals enter the United States,
				  they are subject to all applicable requirements of this subchapter.